ClinicalTrials.gg
Status unknownNCT03481478Updated Mar 29, 2018

Detecting Occult Proximal Humeral Neck Fractures Through CT and MRI Tests of Patients With Greater Tuberosity Fractures

An observational study in Humeral Greater Tuberosity, Humeral Fractures/ Proximal and Fractures/ Occult, sponsored by Hebei Medical University Third Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-29.

Sponsored by Hebei Medical University Third Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Patients with greater tuberosity fractures is becoming increasingly common, as is the number of cases of humeral surgical neck fractures. This study investigated the relationship between size of greater tuberosity fragment and occurrence of humeral surgical neck fractures by using CT or MRI tests.

Read the detailed description

Some humeral surgical neck fractures can be detected through X-ray of shoulder in patients with greater tuberosity fractures. However, some fractures can not be find through conventional X-ray in such patients unless broader CT or MRI tests are required to confirm diagnoses of humeral surgical neck fractures.

02

Conditions studied

  • Humeral Greater Tuberosity
  • Humeral Fractures/ Proximal
  • Fractures/ Occult

Keywords

  • occult
  • proximal humeral neck fractures
  • greater tuberosity
  • shoulder dislocation
03

In context

Shoulder Fractures

113 studies on the registry are indexed under Shoulder Fractures; 30 are open to participants now.

This study's planned enrollment of 100 is close to the median of 97 across 60 observational studies indexed under Shoulder Fractures.

Browse Shoulder Fractures studies →

Lead sponsor

Hebei Medical University Third Hospital is the lead sponsor of 29 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patient demographics, comorbidities, injury mechanisms and other variables were recorded and calculated for each case.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients 18 years or older with greater tuberosity fractures and shoulder dislocation/ or not who were acute injured were included

Exclusion criteria

Exclusion Criteria:

  • Patients with ipsilateral previous proximal humeral fractures and obviously proximal humeral fractures were excluded。
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with greater tuberosity fractures

    If humeral surgical neck fractures can be detected through CT or MRI in such groups.

    Diagnostic Test: CT and MRI

  • Dislocation patients with greater tuberosity fractures

    If humeral surgical neck fractures can be detected through CT or MRI in such groups.

    Diagnostic Test: CT and MRI

Interventions

  • Diagnostic testCT and MRI

    For such patients, using CT and/or MRI to find if existing humeral surgical neck fractures.

06

What researchers measure

Primary outcomes

  1. Humeral surgical neck fractures can be detected through CT/MRI.

    Some greater tuberosity fractures with/or not shoulder dislocation can combined with humeral surgical neck fractures,which can be detected through CT/MRI

    Time frame: 31/12/2018

07

Study locations

1 of 1 sites recruiting
  • Hebei Medical University Third Hospital
    Shijiazhuang, Hebei 050051, China
    Recruiting
    • Zhiyong Hou, M.D · Contacthouzhiyong1234@126.com · +8618533112800
    • Ruipeng Zhang, M.D · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 29, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03481478
Lead sponsor
Hebei Medical University Third Hospital
Responsible party
Sponsor
First posted
Mar 29, 2018
Start date
Mar 24, 2018
Primary completion
Oct 31, 2018 (estimated)
Completion
Dec 31, 2018 (estimated)
Last update
Mar 29, 2018

Study contacts

Hou Zhiyong, MD
Contact
drzyhou@gmail.com
+86 18533112800
Guo Junfei, MD
Contact
drjfguo@163.com
+86 18231181811
Guo Junfei, MD
study director · Hebei Medical University Third Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion